Back to top
more

Inogen (INGN)

(Delayed Data from NSDQ)

$9.62 USD

9.62
227,645

-0.08 (-0.83%)

Updated Oct 1, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Inogen's Solid Europe Business Shapes Q2, Prospects Bright

Inogen's (INGN) Europe performance solid in Q2; guidance for 2018 encourages.

    Bio-Rad (BIO) Banks on Blood Typing Market Amid Margin Woes

    Bio-Rad (BIO) actively expands portfolio for blood typing market; declining gross margin a concern.

      Surmodics' (SRDX) IVD Unit Boosts Growth, R&D Focus Solid

      Surmodics' (SRDX) strong focus on R&D to provide it a competitive edge in the MedTech space.

        Boston Scientific to Expand Within PI Via VENITI Buyout

        Presence of venous obstructive disease visibly grows across the globe, indicating huge prospects for Boston Scientific (BSX) in the treatment market.

          Becton, Dickinson Global Foothold Strong, Recalls Rampant

          Becton, Dickinson (BDX) gains from solid global foothold in Q3; foreign exchange headwinds raise concern.

            Here's Why You Should Dump DENTSPLY (XRAY) Stock Right Now

            DENTSPLY (XRAY) incurs goodwill and intangible impairment charge. A lowered guidance is a concern.

              Here's Why You Should Hold on to Ecolab (ECL) Stock Now

              Ecolab (ECL) is likely to gain from a robust product portfolio, new product launches and expanding customer base.

                Varian Acquires humediQ, Boosts Motion Management Portfolio

                Varian (VAR) incorporates humediQ's coveted IDENTIFY technology in its comprehensive suite of oncology solutions.

                  Inogen (INGN) Beats on Q2 Earnings, Lifts '18 Sales Guidance

                  Inogen (INGN) puts up solid segmental show in Q2; international sales surge.

                    Inogen (INGN) Q2 Earnings and Revenues Top Estimates

                    Inogen (INGN) delivered earnings and revenue surprises of 47.73% and 19.16%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                      RTIX or INGN: Which Is the Better Value Stock Right Now?

                      RTIX vs. INGN: Which Stock Is the Better Value Option?

                        LivaNova (LIVN) Soars: Stock Adds 10.4% in Session

                        LivaNova (LIVN) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

                          Can Solid European Sales Boost Inogen (INGN) in Q2 Earnings?

                          Strong performance in Europe is likely to boost Inogen's (INGN) top line in Q2. However, decline rental-revenues is a concern.

                            Integer Holdings (ITGR) Catches Eye: Stock Jumps 7.5%

                            Integer Holdings (ITGR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

                              Here's Why You Should Add Inogen (INGN) to Your Portfolio

                              Inogen's (INGN) solid product portfolio is a key catalyst. Also, the company benefits from strong focus in Europe.

                                Zacks.com featured highlights include: Johnson Outdoors, Home, Inogen, Blucora and Weight Watchers

                                Zacks.com featured highlights include: Johnson Outdoors, Home, Inogen, Blucora and Weight Watchers

                                  5 Profitable Stocks to Scoop Up Spectacular Returns

                                  Profitability analysis is one of the best tools to evaluate the future movement of a stock.

                                    Stryker or Baxter: Which is a Better Pick for Your Portfolio?

                                    Stryker (SYK) and Baxter's (BAX) strong expected growth rates and rising share price make them close contenders in the MedTech industry.

                                      Sweta Killa headshot

                                      Is SPDR S&P Health Care Equipment ETF (XHE) a Hot ETF Right Now?

                                      Smart Beta ETF report for XHE

                                        Inogen (INGN) Beats Q1 Earnings Estimates, Lifts 2018 View

                                        Inogen (INGN) rides on strong domestic and international sales growth in Q1; a raised guidance buoys optimism.

                                          What's in the Cards for Inogen (INGN) This Earnings Season?

                                          Inherent benefits of POCs, direct-to-customer business model, underpenetrated international markets and expanding product portfolio are key growth catalysts for Inogen (INGN) in Q1.

                                            Why Is Inogen (INGN) Down 7% Since its Last Earnings Report?

                                            Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                              Inogen (INGN) Beats Earnings and Revenue Estimates in Q4

                                              Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.

                                                Healthcare, Vertex to Drive 3D Systems (DDD) Q4 Earnings?

                                                Strong prospects in 3D Systems' (DDD) healthcare business and Vertex brand are likely to prove conductive to its profitability in the to-be-reported quarter.

                                                  Is a Beat in Store for Inogen (INGN) This Earnings Season?

                                                  Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.